Hanaoka K, Hayasaka M, Noguchi T, Kato Y
Laboratory of Mammalian Developmental Biology, Mitsubishi-Kasei Institute of Life Sciences, Tokyo, Japan.
Differentiation. 1991 Nov;48(2):83-7. doi: 10.1111/j.1432-0436.1991.tb00246.x.
A euploid testicular teratocarcinoma line, STT-3, has been established from a tumor spontaneously occurring in the testis of a 129/Sv-ter male. Developmental ability of the STT-3 stem cells was tested by injecting these cells into mouse blastocysts. The frequency and the extent of chimerism were examined in mid-gestational fetuses and in live-born mice. STT-3 stem cells form viable chimeras at a high rate and differentiate into normal tissues. This is the first reported testicular teratocarcinoma-derived stem line with a proven capacity to form viable chimeric mice upon injection into the blastocysts.